Advances in the management of gout: Critical appraisal of febuxostat in the control of hyperuricemia
Lada Beara-Lasic1,3, Michael H Pillinger2,3, David S Goldfarb1,31Divisions of Nephrology and 2Rheumatology, Department of Medicine, NYU Langone Medical Center, New York, NY, USA; 3Department of Medicine, New York Harbor VA Health Care System, New York, NY, USAAbstract: Gout recently passed rheumatoi...
Main Authors: | Lada Beara-Lasic, Michael H Pillinger, David S Goldfarb |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-02-01
|
Series: | International Journal of Nephrology and Renovascular Disease |
Online Access: | http://www.dovepress.com/advances-in-the-management-of-gout-critical-appraisal-of-febuxostat-in-a3952 |
Similar Items
-
FEBUXOSTAT FOR TREATMENT OF CHRONIC HYPERURICEMIA IN GOUT PATIENTS
by: M. S. Petrova, et al.
Published: (2017-11-01) -
Response to febuxostat according to clinical subtypes of hyperuricemia: a prospective cohort study in primary gout
by: Han Qi, et al.
Published: (2023-12-01) -
The place of febuxostat in the treatment of gout
by: A. M. Novikova, et al.
Published: (2020-09-01) -
Febuxostat is a novel drug in therapy for gout
by: V G Barskova, et al.
Published: (2011-04-01) -
Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01)